153 related articles for article (PubMed ID: 23973878)
21. High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus.
Vordenbäumen S; Böhmer P; Brinks R; Fischer-Betz R; Richter J; Bleck E; Rengers P; Göhler H; Zucht HD; Budde P; Schulz-Knappe P; Schneider M
Rheumatology (Oxford); 2018 Mar; 57(3):533-537. PubMed ID: 29267954
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus.
Stummvoll GH; Fritsch RD; Meyer B; Hoefler E; Aringer M; Smolen JS; Steiner G
Ann Rheum Dis; 2009 Jan; 68(1):110-6. PubMed ID: 18375534
[TBL] [Abstract][Full Text] [Related]
23. A branched, synthetic octapeptide of ubiquitinated histone H2A as target of autoantibodies.
Plaué S; Muller S; van Regenmortel MH
J Exp Med; 1989 May; 169(5):1607-17. PubMed ID: 2541220
[TBL] [Abstract][Full Text] [Related]
24. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
[TBL] [Abstract][Full Text] [Related]
25. Preferential recognition of peroxynitrite damaged thymidine-monophosphate by anti-DNA autoantibodies in systemic lupus erythematosus.
Rasheed Z; Al-Shobaili HA; Al Robaee AA; Alzolibani AA; Wadi WI; Khan MI; Al-Hamed HA
Nucleosides Nucleotides Nucleic Acids; 2012; 31(10):736-51. PubMed ID: 23067125
[TBL] [Abstract][Full Text] [Related]
26. [Study on anti-histone fraction antibodies in patients with rheumatic diseases].
Jiang M; He K; Yan CL
Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):287-9, 317-8. PubMed ID: 1478127
[TBL] [Abstract][Full Text] [Related]
27. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone.
Gohill J; Cary PD; Couppez M; Fritzler MJ
J Immunol; 1985 Nov; 135(5):3116-21. PubMed ID: 2413112
[TBL] [Abstract][Full Text] [Related]
28. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.
Burlingame RW; Boey ML; Starkebaum G; Rubin RL
J Clin Invest; 1994 Jul; 94(1):184-92. PubMed ID: 8040259
[TBL] [Abstract][Full Text] [Related]
29. Physicochemical and immunological studies on mitochondrial DNA modified by peroxynitrite: implications of neo-epitopes of mitochondrial DNA in the etiopathogenesis of systemic lupus erythematosus.
Al-Shobaili HA; Rasheed Z
Lupus; 2013 Sep; 22(10):1024-37. PubMed ID: 23884988
[TBL] [Abstract][Full Text] [Related]
30. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
[TBL] [Abstract][Full Text] [Related]
31. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
[TBL] [Abstract][Full Text] [Related]
32. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE.
D'souza A; Kurien BT; Rodgers R; Shenoi J; Kurono S; Matsumoto H; Hensley K; Nath SK; Scofield RH
BMC Med Genet; 2008 Jul; 9():62. PubMed ID: 18606005
[TBL] [Abstract][Full Text] [Related]
33. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies.
Uchida K; Itakura K; Kawakishi S; Hiai H; Toyokuni S; Stadtman ER
Arch Biochem Biophys; 1995 Dec; 324(2):241-8. PubMed ID: 8554315
[TBL] [Abstract][Full Text] [Related]
34. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
35. Putative sequences on Ro60 three-dimensional structure accessible for 4-hydroxy-2-nonenal (HNE) modification compared to in vitro HNE modification of Ro60 sequences.
Kurien BT; D'Souza A; Terzyan S; Scofield RH
Mol Immunol; 2012 Apr; 50(4):185-92. PubMed ID: 22336572
[TBL] [Abstract][Full Text] [Related]
36. Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps.
Dwivedi N; Upadhyay J; Neeli I; Khan S; Pattanaik D; Myers L; Kirou KA; Hellmich B; Knuckley B; Thompson PR; Crow MK; Mikuls TR; Csernok E; Radic M
Arthritis Rheum; 2012 Apr; 64(4):982-92. PubMed ID: 22034172
[TBL] [Abstract][Full Text] [Related]
37. Circulating autoantibodies in cancer patients have high specificity for glycoxidation modified histone H2A.
Mir AR; Moinuddin ; Islam S
Clin Chim Acta; 2016 Jan; 453():48-55. PubMed ID: 26656310
[TBL] [Abstract][Full Text] [Related]
38. Combination of autoantibodies against different histone proteins influences complement-dependent phagocytosis of necrotic cell material by polymorphonuclear leukocytes in systemic lupus erythematosus.
Gullstrand B; Lefort MH; Tydén H; Jönsen A; Lood C; Johansson A; Jacobsen S; Truedsson L; Bengtsson AA
J Rheumatol; 2012 Aug; 39(8):1619-27. PubMed ID: 22753651
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal anti-histone autoantibodies derived from murine models of lupus.
Kotzin BL; Lafferty JA; Portanova JP; Rubin RL; Tan EM
J Immunol; 1984 Nov; 133(5):2554-9. PubMed ID: 6332855
[TBL] [Abstract][Full Text] [Related]
40. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies.
Ben Mansour R; Lassoued S; Elgaied A; Haddouk S; Marzouk S; Bahloul Z; Masmoudi H; Attia H; Aïfa MS; Fakhfakh F
Scand J Rheumatol; 2010 May; 39(3):247-53. PubMed ID: 20429675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
